Market Place
Sourcing Support
JCR Pharma & Alexion Hit Milestone in Neurodegenerative Program
19 Sep 2025 //
PHARMAWEB
AZ`s Alexion Highlights gMG in Upcoming Awareness Film
31 Jul 2025 //
FIERCE PHARMA
US FDA approves Amgen`s biosimilar to AZ`s rare blood disorder treatment
29 May 2024 //
REUTERS
Lights, camera and community: AZ’s Alexion creates an original film
11 Apr 2024 //
FIERCE BIOTECH
VOYDEYA™ Approved in The US & Ravulizumab or Eculizumab for the Rare Disease
01 Apr 2024 //
BUSINESSWIRE
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo
19 Mar 2024 //
BUSINESSWIRE
Alexion, AZ Rare Disease, Completes Acquisition of LogicBio Therapeutics
16 Nov 2022 //
BUSINESSWIRE
AZ expands global footprint in rare disease with availability of first Alexion
11 Nov 2022 //
PRESS RELEASE
Alexion aims to advance NMOSD treatment landscape with ULTOMIRIS efficacy data
12 Oct 2022 //
BUSINESSWIRE
Alexion, AstraZeneca Rare Disease to Acquire LogicBio
04 Oct 2022 //
PRNEWSWIRE
Alexion Announces Upcoming Data Presentations at the 26th EHA Virtual Congress
12 May 2021 //
GLOBENEWSWIRE
Alexion bags option on Stealth`s phase 3 rare disease drug
11 Oct 2019 //
FIERCE PHARMA
FDA puts the brakes on a rare disease biotech’s PhIII as regulators
24 Sep 2019 //
ENDPTS
Alexion targets big Ultomiris goals with early switching success
05 Feb 2019 //
FIERCE PHARMA
Alexion $60M option for a lucrative rare blood disease
31 Jan 2019 //
ENDPTS
Alexion’s Soliris follow-up clears trial in aHUS, its second rare disease
29 Jan 2019 //
FIERCE BIOTECH
Alexion needs a new sticker-price plan With pivot to less-rare diseases
09 Jan 2019 //
FIERCE PHARMA
USFDA approves Portola Pharmaceuticals’ Andexxa®
07 Jan 2019 //
BIOSPECTRUM
FDA gifts Alexion quick OK for Soliris follow-up Ultomiris
27 Dec 2018 //
FIERCE PHARMA
Roche May Have A Competing Drug For A Rare Disease
27 Dec 2018 //
SEEKING ALPHA
Teva successfully used a rare pediatric PRV to speed the approval for Ajovy
21 Nov 2018 //
RAPS
Keeping up deal frenzy, Alexion strikes an RNAi pact
25 Oct 2018 //
BIOPHARMA DIVE
Alexion crowns myasthenia gravis as its best Soliris launch ever
25 Oct 2018 //
FIERCE PHARMA
Alexion to Acquire Syntimmune
27 Sep 2018 //
BUSINESSWIRE
Alexion to Present on Rare Disease & Oncology
26 Sep 2018 //
BUSINESSWIRE
Could Amgen soften the biosim blow with an Alexion buy?
16 Jul 2018 //
FIERCE PHARMA
Abeona taps ex-Alexion CCO as new chief, eyeing commercial ops
03 Apr 2018 //
FIERCE BIOTECH
Elliott Management seeks changes at Alexion: NYT
07 Dec 2017 //
REUTERS
US expands use of Alexion rare disease therapy Soliris
25 Oct 2017 //
PHARMA TIMES
Alexion and Sema4 partner in rare disease diagnostics
11 Aug 2017 //
PHARMA TIMES
NICE broadens access to Alexion`s rare disease drug Strensiq
06 Jul 2017 //
PMLIVE
3 Biotechs With Bulging Pipelines Could Also Become Attractive Takeover Targets
30 Jun 2017 //
BIOSPACE
FDA outlines plan to speed rare disease drug designation
29 Jun 2017 //
REUTERS
Alexion Brazil office allegedly committed medical fraud for rare disease
09 May 2017 //
PLUSS
Alexion (ALXN) Licenses Artubus Technology for Rare Diseases
18 Mar 2017 //
FINANCE YAHOO
